Suven Life Sciences gets patents for neurological drug
Suven Life Sciences gets patents for neurological drug
-
What Is Wrong with Orphan Drug Policies?
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s1098301512041290-mainDownload
-
Amicus Briefs On Biosimilar Patent Litigation – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 23 APRIL 2015POSTED IN BIOSIMILARSAmgen has appealed the district court decision denying its motion for a...
-
Merck scores victory in India patent battle over top diabetes meds! – Courtesy (Fierce Pharma)
Pharma Live, , Intellectual Property Rights, 0
In a potentially promising sign for Western drugmakers, Merck ($MRK) scored a victory in its patent battle with India’s Glenmark...
-
The new drugs war – Courtesy (The Economists)
Pharma Live, , Intellectual Property Rights, 0
OF ALL the goods and services traded in the market economy, pharmaceuticals are perhaps the most contentious. Though produced...
-
Priority setting for orphan drugs: An international comparison
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0168851010002691-mainDownload
-
Novo Nordisk rejects Baxter patent claim over Novoeight
Pharma Live, , Intellectual Property Rights, 0
COPENHAGEN, May 20 (Reuters) – Novo Nordisk said on Wednesday it rejected claims by U.S. rival Baxter International that...
-
Telmisartan: no double-dipping says CJEU, as it avoids answering all the questions – Courtesy (The SPC Blog)
Pharma Live, , Intellectual Property Rights, 0
The Court of Justice of the European Union (CJEU) delivered its ruling in Case C‑577/13, Actavis Group PTC EHF, Actavis UK...
-
FDA Releases Draft Guidance on Biosimilars
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 9 FEBRUARY 2012POSTED IN BIOSIMILARSOn February 9, 2012, the FDA issued long-awaited (draft) guidance documents on...